Customized Science,

Made in the USA.

Integrated CDMO – Pharmaceutical, Cannabinoids

and Controlled Substances

About Us

Based in Round Rock, just north of Austin, Texas, Benuvia Manufacturing provides small molecule active pharmaceutical ingredients (APIs), formulation, and drug product manufacturing from preclinical to commercial scale.

We have fully integrated quality management systems in place including in-house auditors who conduct regular facility audits and external qualifications of all raw material and component suppliers to ensure the highest level of compliance.

cGMP Facility

DEA Permitted

FDA Inspected

Cannabinoids

Full-Scale capabilities under one roof, Benuvia Manufacturing offers high purity Pharmaceutical cannabinoid ingredients, small molecule APIs and drug products. Starting with analytical and process development, we offer comprehensive technology solutions for Active Pharmaceutical Ingredient and drug product development.

Learn More

Entheogens

Nimble and reliable CDMO whose sole mission is to provide best in class pharmaceutical development services, focused on challenging chemistries, high-value and low-volume APIs. We are dedicated to transforming the treatment of psychiatric and neurological disorders through innovative drug product development that meets today’s needs.

Psychedelics Manufacturing Registration in place

Learn More

Inhalation Capabilities

A fundamental goal of Benuvia is to assist companies with the development of novel pMDI devices that incorporate Active Pharmaceutical Ingredients (ex: Cannabinoids and Psychedelics) for the treatment of CNS and other diseases. Benuvia has formulation, fill and finish capabilities to meet pMDI development requirements.

Learn More

Benuvia Clients

News & Events

Benuvia, a Drug Developer Focused on Pharmaceutical Cannabinoids, and the owner of FDA Approved SYNDROS®, Receives Approval from the US DEA to Manufacture Psychedelic Active Pharmaceutical Ingredients including Psilocybin, MDMA and DMT

May 16, 2022

With this approval, Benuvia has begun focusing on four primary psychedelic ingredients: Psilocybin, N,N-Dimethyl-5-Methoxy-Tryptamine (5-MeO DMT), Dimethyltryptamine (DMT), and 3,4-Methylenedioxymethamphetamine, or MDMA Benuvia will manufacture psychedelic APIs in its...